Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.
In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome).
Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.
What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.
The National Corporate Account Director, Oncology is responsible for assigning specialty distributor(s), specialty pharmacy(s), community GPO accounts, trade organization(s) and targeted community oncology key accounts with in-practice dispensing capabilities to support patient access.
Responsibilities:
- Execute the specialty distribution, community GPO, and key account strategies to ensure appropriate practice adoption and patient access
- Negotiate specialty distribution (SDs) service agreements and related agreements, and maintain agreed upon service levels. Perform periodic business reviews
- Negotiate service and data-sharing agreements with assigned oncology Specialty Pharmacy partners to meet brand objectives
- Coordinate periodic business reviews
- Identify and manage the execution of educational opportunities with assigned community oncology GPOs (ie Unity, Onmark, ION, etc.) to inform GPO members and support patient access through GPO meeting sponsorships opportunities and in-practice programs
- Negotiate and manage GPO contracts to support patient access through in-practice dispensing
- Manage relationships with community oncology key accounts with in-practice dispensing capabilities and centralized decision making
- Collaborate with the field sales team to ensure coordination in key community oncology accounts
- Support partnerships with assigned oncology trade organizations such as COA and NCODA
- Analyze product volume, trends, and growth, for assigned accounts. Develop and implement account level business plans and work with market access marketing to develop segment strategies and resources
- Monitor and ensure that partners adhere to contract terms
Preferred Skills, Qualifications and Technical Proficiencies:
- Experience in oncology specialty distribution, specialty pharmacy, community oncology GPO, and community oncology key account management
- Extensive customer relationships and experience
- Experience launching oral oncology therapies in the community oncology setting with a focus on driving results and meeting or exceeding objectives
- Demonstrated ability to meet assigned objectives and drive results within agreed upon timelines
- Effective oral and written communication skills and ability to engage at all levels of the organization including C-Suite level relationships
- Excellent negotiation skills with a focus on finding solutions to meet organizational goals
- Collaborative work and communication style fostering cross-functional teamwork
- Working knowledge of US healthcare policies and relevant legal, compliance, regulatory, and reporting requirements
Preferred Education and Experience:
- Bachelor’s Degree; Master’s degree preferred
- Strategic mindset and patient-centric approach to the business
- Ability to thrive in a fast-paced, dynamic environment
- 10+ years of pharmaceutical industry experience including current and/or previous oncology experience
- 5+ years of related assigned account experience
- Pharmaceutical field sales leadership experience preferred
The pay range that the Company reasonably expects to pay for this position is $232,800 - $273,800; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.
#LI-Remote
Applicants must be currently authorized to work in the United States on a full-time basis.
For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link.
Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.
Please visit our website at: https://www.corcept.com/
Corcept is an Equal Opportunity Employer
Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.
What We Do
Leading the field in the discovery of drugs that modulate the effects of cortisol.
The adverse effects of excess cortisol have been Corcept’s focus since the company’s inception. Abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol.
